BackInnate Pharma Overview

Innate Pharma Research & Development

Research & Development expenses for IPHA.

Quarterly R&D Expenses

$22.93M
↑ 0.11% YoY

As of Dec 31, 2025

Annual R&D Expenses (TTM)

$80.89M
↑ 2.45% YoY

Trailing 12 months ending Dec 31, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin